NO20084614L - Perkutanose absorpsjonspreparater omfattende antidemensmedikamenter - Google Patents

Perkutanose absorpsjonspreparater omfattende antidemensmedikamenter

Info

Publication number
NO20084614L
NO20084614L NO20084614A NO20084614A NO20084614L NO 20084614 L NO20084614 L NO 20084614L NO 20084614 A NO20084614 A NO 20084614A NO 20084614 A NO20084614 A NO 20084614A NO 20084614 L NO20084614 L NO 20084614L
Authority
NO
Norway
Prior art keywords
drug
percutaneous absorption
skin
antidepressant
antidepressant drugs
Prior art date
Application number
NO20084614A
Other languages
English (en)
Norwegian (no)
Inventor
Takeshi Ito
Original Assignee
Teikoku Seiyaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teikoku Seiyaku Kk filed Critical Teikoku Seiyaku Kk
Publication of NO20084614L publication Critical patent/NO20084614L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20084614A 2006-05-08 2008-10-31 Perkutanose absorpsjonspreparater omfattende antidemensmedikamenter NO20084614L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79829606P 2006-05-08 2006-05-08
PCT/JP2006/325813 WO2007129427A1 (ja) 2006-05-08 2006-12-25 抗認知症薬物の経皮吸収製剤

Publications (1)

Publication Number Publication Date
NO20084614L true NO20084614L (no) 2009-02-06

Family

ID=38667540

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20084614A NO20084614L (no) 2006-05-08 2008-10-31 Perkutanose absorpsjonspreparater omfattende antidemensmedikamenter

Country Status (16)

Country Link
US (2) US7858114B2 (enExample)
EP (1) EP2016939B1 (enExample)
JP (1) JP5122445B2 (enExample)
KR (1) KR20090009951A (enExample)
CN (1) CN101460156B (enExample)
AU (1) AU2006343077B2 (enExample)
BR (1) BRPI0621655A2 (enExample)
CA (1) CA2651596C (enExample)
ES (1) ES2466647T3 (enExample)
IL (1) IL195174A0 (enExample)
IN (1) IN266817B (enExample)
MY (1) MY149152A (enExample)
NO (1) NO20084614L (enExample)
NZ (1) NZ572809A (enExample)
RU (1) RU2428179C2 (enExample)
WO (1) WO2007129427A1 (enExample)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101573115B (zh) * 2006-12-01 2012-06-06 日东电工株式会社 抑制含有多奈哌齐的贴剂着色的方法、及降低多奈哌齐类似物的生成量的方法
KR101408488B1 (ko) * 2006-12-01 2014-06-17 닛토덴코 가부시키가이샤 도네페질 함유 접착 제제의 경시적인 변색을 억제하는 방법
CA2719605C (en) * 2008-03-25 2016-07-12 Teikoku Seiyaku Co., Ltd. Transdermally absorbable preparation
US20090291127A1 (en) * 2008-05-21 2009-11-26 Jianye Wen Transdermal anti-dementia active agent formulations and methods for using the same
EP2279739B2 (en) * 2008-05-30 2018-02-28 Nitto Denko Corporation Donepezil-containing patch preparation and packaging thereof
BRPI0912099A2 (pt) * 2008-05-30 2015-10-06 Eisai R&D Man Co Ltd preparação percutaneamente absorvível
US20100080842A1 (en) * 2008-09-30 2010-04-01 Jianye Wen Transdermal extended-delivery donepezil compositions and methods for using the same
US8858983B2 (en) 2009-04-30 2014-10-14 Medtronic, Inc. Antioxidants and antimicrobial accessories including antioxidants
KR101325104B1 (ko) * 2009-09-16 2013-11-07 주식회사 삼양바이오팜 경피 투여 제형 및 그 제조 방법
KR20120101704A (ko) * 2009-12-16 2012-09-14 고토 다케시 항인지증 약물의 경피흡수제제
JP2012236773A (ja) * 2009-12-16 2012-12-06 Goto Takeshi 抗認知症薬物の経皮吸収製剤
TW201143817A (en) * 2009-12-16 2011-12-16 Goto Takeshi Transdermally absorbed preparation of anti-dementia drug
US10076502B2 (en) 2009-12-22 2018-09-18 Luye Pharma Ag Transdermal therapeutic system for administering rivastigmine or derivatives thereof
US8962014B2 (en) * 2009-12-22 2015-02-24 Acino Ag Transdermal therapeutic system for administering rivastigmine or derivatives thereof
US20100178307A1 (en) * 2010-01-13 2010-07-15 Jianye Wen Transdermal anti-dementia active agent formulations and methods for using the same
NZ605352A (en) * 2010-06-30 2013-10-25 Nal Pharmaceuticals Ltd Process for producing glycosaminoglycans
RS54173B1 (sr) 2010-12-14 2015-12-31 Acino Ag Transdermalni terapijski sistem za davanje aktivne supstance
US8911427B2 (en) * 2010-12-28 2014-12-16 Medtronic, Inc. Therapeutic agent reservoir delivery system
TWI433904B (zh) * 2011-01-12 2014-04-11 Taiwan Biotech Co Ltd 多奈哌齊經皮貼片
KR101054317B1 (ko) 2011-01-28 2011-08-08 신신제약 주식회사 리바스티그민을 함유하는 경피흡수제제
KR101317158B1 (ko) 2011-02-18 2013-10-15 조선대학교산학협력단 갈란타민 또는 그의 염을 함유하는 경피흡수제제
BR112013029945A2 (pt) * 2011-05-20 2017-01-31 Sk Chemicals Co Ltd emplastro contendo rivastigmina
KR101395557B1 (ko) * 2011-08-25 2014-05-16 아이큐어 주식회사 경피 흡수 제제 및 그 제조방법
KR101239150B1 (ko) 2012-02-28 2013-03-06 에스케이케미칼주식회사 도네페질-함유 경피흡수제제 및 그의 제조방법
KR101964295B1 (ko) * 2012-09-05 2019-04-01 주식회사 한독 피부 자극이 감소된 메만틴 경피전달 시스템
KR102171152B1 (ko) * 2012-12-13 2020-10-29 하. 룬드벡 아크티에셀스카브 보르티옥세틴 및 도네페질을 포함하는 조성물
JP6151935B2 (ja) * 2013-03-11 2017-06-21 日東電工株式会社 経皮吸収促進用組成物および貼付製剤
CN106456562B (zh) 2014-02-20 2020-01-31 安能泰制药有限公司 含有多奈哌齐的透皮药物递送系统
EP3310348B1 (en) 2015-06-22 2020-08-05 Corium, Inc. Transdermal adhesive composition comprising a poorly soluble therapeutic agent
JP6148416B2 (ja) 2015-06-29 2017-06-14 積水化学工業株式会社 コアシェル構造体及び外用剤
US10966936B2 (en) 2015-12-30 2021-04-06 Corium, Inc. Systems comprising a composite backing and methods for long term transdermal administration
CA3028436A1 (en) 2016-06-23 2017-12-28 Corium International, Inc. Adhesive matrix with hydrophilic and hydrophobic domains and a therapeutic agent
MX2019001104A (es) * 2016-07-27 2019-10-02 Corium Int Inc Sistemas de suministro transdermico de memantina.
WO2018022814A1 (en) * 2016-07-27 2018-02-01 Corium International, Inc. Transdermal delivery systems with pharmacokinetics bioequivalent to oral delivery
US9993466B2 (en) * 2016-07-27 2018-06-12 Corium International, Inc. Donepezil transdermal delivery system
RU2748651C2 (ru) * 2017-02-28 2021-05-28 Кимберли-Кларк Ворлдвайд, Инк. Синергическая композиция для сохранения здорового баланса микрофлоры
CN108096690B (zh) * 2017-04-07 2019-08-20 杭州多泰科技有限公司 一种诱导循环肿瘤细胞转移的可移植支架的制备方法
KR102033686B1 (ko) 2017-05-19 2019-10-18 보령제약 주식회사 도네페질을 함유하는 마이크로니들 경피 패치
CN111132669A (zh) * 2017-07-26 2020-05-08 考里安公司 具有带溶剂填充孔的微孔膜的透皮递送系统
CA3085342A1 (en) 2017-12-13 2019-06-20 Corium, Inc. Method for depot creation during transdermal drug delivery
US11173132B2 (en) 2017-12-20 2021-11-16 Corium, Inc. Transdermal adhesive composition comprising a volatile liquid therapeutic agent having low melting point
CN108926549A (zh) * 2018-09-27 2018-12-04 安徽安科余良卿药业有限公司 卡巴拉汀凝胶贴膏及其制备方法
US20220175812A1 (en) 2020-12-03 2022-06-09 Battelle Memorial Institute Polymer nanoparticle and dna nanostructure compositions and methods for non-viral delivery
JP2024516108A (ja) 2021-04-07 2024-04-12 バテル・メモリアル・インスティテュート 非ウイルス性担体を同定および使用するための迅速な設計、構築、試験、および学習技術
KR102489860B1 (ko) * 2021-09-02 2023-01-19 동아에스티 주식회사 메만틴 에난트산염을 포함하는 치매 치료용 경피흡수 제제
CN115957200A (zh) * 2023-02-23 2023-04-14 广州新济药业科技有限公司 一种美金刚透皮贴剂及制备方法
WO2025072751A1 (en) 2023-09-29 2025-04-03 Battelle Memorial Institute Polymer nanoparticle compositions for in vivo expression of polypeptides
US12441996B2 (en) 2023-12-08 2025-10-14 Battelle Memorial Institute Use of DNA origami nanostructures for molecular information based data storage systems

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI921121A0 (fi) 1989-09-14 1992-03-16 Cygnus Research Corp Transdermal doseringsanordning med foerdroejd start.
JP2977254B2 (ja) 1990-09-04 1999-11-15 積水化学工業株式会社 経皮吸収貼付剤
US5273756A (en) 1991-08-23 1993-12-28 Cygnus Therapeutic Systems Transdermal drug delivery device using a membrane-protected microporous membrane to achieve delayed onset
JPH06199659A (ja) * 1992-10-28 1994-07-19 Hisamitsu Pharmaceut Co Inc 経皮治療用装置
ATE149349T1 (de) * 1993-06-25 1997-03-15 Alza Corp Einarbeitung eines poly-n-vinylamids in ein transdermales system
FR2717689B1 (fr) * 1994-03-28 1996-07-05 Lhd Lab Hygiene Dietetique Système matriciel transdermique d'administration d'un oestrogène et/ou un progestatif à base de copolymère styrène-isoprène-styrène.
US5635203A (en) 1994-09-29 1997-06-03 Alza Corporation Transdermal device having decreased delamination
DE19533772C1 (de) * 1995-09-12 1998-01-02 Hexal Ag Tacrin/Selegilin-Pflaster
DE19653605C2 (de) * 1996-12-20 2002-11-28 Roehm Gmbh Haft- und Bindemittel für dermale oder transdermale Therapiesysteme und dessen Verwendung zur Herstellung eines transdermalen Therapiesystems
JPH10315016A (ja) 1997-05-15 1998-12-02 Nissan Diesel Motor Co Ltd チャック装置
JP3987655B2 (ja) * 1998-03-03 2007-10-10 エーザイ・アール・アンド・ディー・マネジメント株式会社 抗痴呆薬を含有した経皮適用製剤又は坐剤
DE19918106A1 (de) * 1999-04-22 2000-10-26 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit neutralisierten Acrylathaftklebern
GB9917290D0 (en) * 1999-07-22 1999-09-22 Glaxo Wellcome Spa Pharmaceutical composition
DE10033853A1 (de) * 2000-07-12 2002-01-31 Hexal Ag Transdermales therapeutisches System mit hochdispersem Siliziumdioxid
FR2814368B1 (fr) * 2000-09-26 2004-05-07 Pf Medicament Preparation pharmaceutique a base d'oxans
JP4057418B2 (ja) * 2000-11-07 2008-03-05 久光製薬株式会社 経皮吸収型製剤
DE10060550C1 (de) 2000-12-06 2002-04-18 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit dem Wirkstoff Oxybutynin und Verfahren zur Herstellung Oxybutynin enthaltender Wirkstoffschichten
JP4394443B2 (ja) * 2001-10-17 2010-01-06 久光製薬株式会社 経皮吸収型製剤
DE10220230A1 (de) * 2002-05-06 2003-11-27 Sanol Arznei Schwarz Gmbh Verwendung von Rotigotine zur Behandlung des Restless Leg Syndroms
JP4274951B2 (ja) * 2004-01-07 2009-06-10 久光製薬株式会社 異型断面繊維を使用した支持体を有するテーピング型貼付剤
JPWO2005115355A1 (ja) * 2004-05-28 2008-03-27 久光製薬株式会社 貼付製剤

Also Published As

Publication number Publication date
EP2016939A1 (en) 2009-01-21
CN101460156A (zh) 2009-06-17
BRPI0621655A2 (pt) 2011-12-20
ES2466647T3 (es) 2014-06-10
AU2006343077A1 (en) 2007-11-15
US7858114B2 (en) 2010-12-28
CA2651596C (en) 2014-03-25
IN266817B (enExample) 2015-06-03
AU2006343077B2 (en) 2012-11-08
MY149152A (en) 2013-07-15
RU2428179C2 (ru) 2011-09-10
JP5122445B2 (ja) 2013-01-16
KR20090009951A (ko) 2009-01-23
HK1130175A1 (en) 2009-12-24
IL195174A0 (en) 2009-08-03
US20070259028A1 (en) 2007-11-08
CN101460156B (zh) 2011-06-08
NZ572809A (en) 2011-02-25
EP2016939B1 (en) 2014-03-19
US20110059141A1 (en) 2011-03-10
RU2008148131A (ru) 2010-06-20
EP2016939A4 (en) 2013-01-09
CA2651596A1 (en) 2007-11-15
JPWO2007129427A1 (ja) 2009-09-17
WO2007129427A1 (ja) 2007-11-15

Similar Documents

Publication Publication Date Title
NO20084614L (no) Perkutanose absorpsjonspreparater omfattende antidemensmedikamenter
EA201000747A1 (ru) Система и способ трансдермальной доставки и способ получения системы трансдермальной доставки
DE602006014990D1 (de) Intranasale verabreichung von schnell wirkendem insulin
WO2008100576A3 (en) Sustained delivery formulations of rapamycin compounds
CY1119582T1 (el) Υδατικα παρασκευασματα ινσουλινης, που περιεχουν μεθειονινη
NO20092998L (no) Flytende formuleringer, som danner dermal film, for frigjoring av legemidler til huden
MX2011006527A (es) Agentes medicinales unidos a dipeptido.
SV2008003106A (es) Composicion farmaceutica estable que contiene docetaxel y un metodo para fabricarla
BRPI0707235B8 (pt) formulação de fentanil sublingual sem propelente, e, dispositivo de dose unitária para administração sublingual de uma formulação de fentanil sublingual
AR047928A1 (es) Derivados de tetrahidropiridoindol
WO2007092620A3 (en) Stable formulations, and methods of their preparation and use
AR060755A1 (es) Formulaciones de inhibidores de dipeptidil peptidasa iv (dpp iv)
CY1108794T1 (el) Σπειροκυκλικα παραγωγα κυκλοεξανιου
EP4218724A3 (en) Microstructure array for delivery of active agents
BR112014001875A2 (pt) sistema e método personalizáveis para anestesiar membrana timpânica
NZ611920A (en) Percutaneous absorption preparation containing rivastigmine
BRPI0609278B8 (pt) método para preparar uma composição farmacêutica e composição farmacêutica
GT200500235A (es) Conjugados de hormona del crecimiento humana y polietilenglicol ramificado con glicerol, proceso para su preparacion y metodos de uso de los mismos
AR043423A1 (es) Sistema de liberacion controlada
ATE427760T1 (de) Erodierbare polymere zur injektion
CY1116638T1 (el) Διαδερμικο θεραπευτικο συστημα για την χορηγηση μιας δραστικης ουσιας
BR112012003283A8 (pt) sal farmaceuticamente aceitável de um agente fotossensibilizante anfifílico, composição farmacêutica, produto, kit, uso de um sal farmaceuticamente aceitável de um agente fotossensibilizante anfifílico, e, método de introdução de uma molécula de medicamento no citosol de uma célula em um paciente.
PH12017501527A1 (en) Oral hemostatic and wound-protective film
CO6400200A2 (es) Preparaciones basadas en fibrinógeno y polisacáridos sulfatados
WO2009060952A1 (ja) 新規製剤

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application